Allergy Therapeutics plc (AGY.L)
GBp 7.0
(2.94%)
GBp 7.0
(2.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -40.21 Million GBP | N/A |
| 2022 | -43.07 Million GBP | -212.65% |
| 2021 | -13.77 Million GBP | -577.34% |
| 2020 | 2.88 Million GBP | -59.11% |
| 2019 | 7.05 Million GBP | 103.58% |
| 2018 | 3.46 Million GBP | 146.02% |
| 2017 | -7.53 Million GBP | -203.63% |
| 2016 | -2.48 Million GBP | 81.02% |
| 2015 | -13.07 Million GBP | -12203.7% |
| 2014 | 108 Thousand GBP | -85.43% |
| 2013 | 741 Thousand GBP | 38.25% |
| 2012 | 536 Thousand GBP | -34.87% |
| 2011 | 823 Thousand GBP | 130.92% |
| 2010 | -2.66 Million GBP | -554.27% |
| 2009 | 586 Thousand GBP | 104.98% |
| 2008 | -11.76 Million GBP | 42.04% |
| 2007 | -20.29 Million GBP | 12.72% |
| 2006 | -23.25 Million GBP | -276.74% |
| 2005 | -6.17 Million GBP | -181.74% |
| 2004 | -2.19 Million GBP | -279.89% |
| 2003 | 1.21 Million GBP | -76.47% |
| 2002 | 5.17 Million GBP | 211.0% |
| 2001 | -4.66 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -15.65 Million GBP | 0.0% |
| 2022 FY | -43.07 Million GBP | -212.65% |
| 2022 Q4 | -34.56 Million GBP | 0.0% |
| 2022 Q2 | -8.5 Million GBP | 0.0% |
| 2021 Q2 | 6.67 Million GBP | 0.0% |
| 2021 FY | -13.77 Million GBP | -577.34% |
| 2021 Q4 | -20.44 Million GBP | 0.0% |
| 2020 Q4 | -12.05 Million GBP | 0.0% |
| 2020 FY | 2.88 Million GBP | -59.11% |
| 2020 Q2 | 14.93 Million GBP | 0.0% |
| 2019 FY | 7.05 Million GBP | 103.58% |
| 2019 Q4 | -8.21 Million GBP | 0.0% |
| 2019 Q2 | 15.27 Million GBP | 0.0% |
| 2018 Q2 | 10.32 Million GBP | 0.0% |
| 2018 Q4 | -6.85 Million GBP | 0.0% |
| 2018 FY | 3.46 Million GBP | 146.02% |
| 2017 Q2 | 6.02 Million GBP | 0.0% |
| 2017 FY | -7.53 Million GBP | -203.63% |
| 2017 Q4 | -13.55 Million GBP | 0.0% |
| 2016 Q2 | 6.84 Million GBP | 0.0% |
| 2016 FY | -2.48 Million GBP | 81.02% |
| 2016 Q4 | -9.32 Million GBP | 0.0% |
| 2015 Q4 | -14.12 Million GBP | 0.0% |
| 2015 Q2 | 1.05 Million GBP | 0.0% |
| 2015 FY | -13.07 Million GBP | -12203.7% |
| 2014 FY | 108 Thousand GBP | -85.43% |
| 2014 Q2 | 7.3 Million GBP | 0.0% |
| 2014 Q4 | -7.19 Million GBP | 0.0% |
| 2013 FY | 741 Thousand GBP | 38.25% |
| 2013 Q4 | -5.48 Million GBP | 0.0% |
| 2013 Q2 | 6.22 Million GBP | 0.0% |
| 2012 Q2 | 4.95 Million GBP | 0.0% |
| 2012 FY | 536 Thousand GBP | -34.87% |
| 2012 Q4 | -4.31 Million GBP | -3323.13% |
| 2012 Q3 | 134 Thousand GBP | -97.29% |
| 2011 Q4 | 205.75 Thousand GBP | 0.0% |
| 2011 Q3 | 205.75 Thousand GBP | 0.0% |
| 2011 FY | 823 Thousand GBP | 130.92% |
| 2011 Q1 | -665.5 Thousand GBP | 0.0% |
| 2011 Q2 | 205.75 Thousand GBP | 130.92% |
| 2010 Q1 | 146.5 Thousand GBP | 0.0% |
| 2010 FY | -2.66 Million GBP | -554.27% |
| 2010 Q4 | -665.5 Thousand GBP | 0.0% |
| 2010 Q3 | -665.5 Thousand GBP | 0.0% |
| 2010 Q2 | -665.5 Thousand GBP | -554.27% |
| 2009 FY | 586 Thousand GBP | 104.98% |
| 2009 Q2 | 146.5 Thousand GBP | 104.98% |
| 2009 Q3 | 146.5 Thousand GBP | 0.0% |
| 2009 Q4 | 146.5 Thousand GBP | 0.0% |
| 2009 Q1 | -2.94 Million GBP | 0.0% |
| 2008 Q2 | -2.94 Million GBP | 42.04% |
| 2008 Q1 | -5.07 Million GBP | 0.0% |
| 2008 Q3 | -2.94 Million GBP | 0.0% |
| 2008 Q4 | -2.94 Million GBP | 0.0% |
| 2008 FY | -11.76 Million GBP | 42.04% |
| 2007 Q4 | -5.07 Million GBP | 0.0% |
| 2007 Q1 | -5.81 Million GBP | 0.0% |
| 2007 Q2 | -5.07 Million GBP | 12.72% |
| 2007 Q3 | -5.07 Million GBP | 0.0% |
| 2007 FY | -20.29 Million GBP | 12.72% |
| 2006 Q1 | -1.54 Million GBP | 0.0% |
| 2006 Q4 | -5.81 Million GBP | 0.0% |
| 2006 Q3 | -5.81 Million GBP | 0.0% |
| 2006 Q2 | -5.81 Million GBP | -276.74% |
| 2006 FY | -23.25 Million GBP | -276.74% |
| 2005 Q1 | -482.25 Thousand GBP | 0.0% |
| 2005 Q2 | -1.54 Million GBP | -220.01% |
| 2005 Q3 | -1.54 Million GBP | 0.0% |
| 2005 Q4 | -1.54 Million GBP | 0.0% |
| 2005 FY | -6.17 Million GBP | -181.74% |
| 2004 Q3 | -482.25 Thousand GBP | 0.0% |
| 2004 Q4 | -482.25 Thousand GBP | 0.0% |
| 2004 Q1 | 304.5 Thousand GBP | 0.0% |
| 2004 Q2 | -482.25 Thousand GBP | -258.37% |
| 2004 FY | -2.19 Million GBP | -279.89% |
| 2003 Q4 | 304.5 Thousand GBP | 0.0% |
| 2003 Q1 | 1.29 Million GBP | 0.0% |
| 2003 FY | 1.21 Million GBP | -76.47% |
| 2003 Q2 | 304.5 Thousand GBP | -76.47% |
| 2003 Q3 | 304.5 Thousand GBP | 0.0% |
| 2002 Q2 | 1.29 Million GBP | 211.0% |
| 2002 FY | 5.17 Million GBP | 211.0% |
| 2002 Q4 | 1.29 Million GBP | 0.0% |
| 2002 Q3 | 1.29 Million GBP | 0.0% |
| 2002 Q1 | -1.16 Million GBP | 0.0% |
| 2001 Q2 | -1.16 Million GBP | 0.0% |
| 2001 Q3 | -1.16 Million GBP | 0.0% |
| 2001 Q4 | -1.16 Million GBP | 0.0% |
| 2001 FY | -4.66 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|